bioMerieux (FR:BIM) has released an update. bioMerieux has received FDA clearance for its VIDAS® TBI test, designed to improve the management of patients with mild traumatic brain injury by predicting ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results